Materials • Major Chemicals
$1.29 ▼ -0.01
(-0.77%)
MKT CAP: $93.1M • VOL: 579.0K
52W L $1 52W H $4
ROARABLE / RQD
E • 34/100
PIOTROSKI
3 / 9
AMTX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $208.0M | $267.6M | $77.2M |
| YoY Revenue Growth % | — | +246.7% | — |
| Gross Profit | -$768.0K | -$580.0K | — |
| Gross Margin % | -0.4% | -0.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$37.2M | -$40.4M | -$37.4M |
| Operating Margin % | -17.9% | -15.1% | -48.5% |
| Net Income (GAAP) | -$77.0M | -$87.5M | -$46.4M |
| EBITDA (Normalized) | -$16.4M | -$24.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.3M | -$32.9M | $13.8M |
| Capital Expenditures (CapEx) | $26.0M | $20.3M | — |
| Free Cash Flow (FCF) | -$22.7M | -$53.2M | $13.8M |
| FCF Margin % | -10.9% | -19.9% | 17.9% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $4.9M | $898.0K | — |
| Total Debt (Short + Long Term) | $63.9M | $247.5M | — |
| Total Stockholders' Equity | -$306.8M | -$263.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AMTX.